Blog

Jun 18

Contraceptive Pearl: Harm Reduction Approaches to Substance Use During Pregnancy

Written by Meghan Hynes Although health care professionals and institutions are evolving from treating addiction as a moral failing to treating it as a chronic disease in recent years, substance use during pregnancy remains misunderstood and heavily stigmatized. This stigmatization can negatively affect how health care professionals perceive patients with substance use disorders (SUDs) and…

May 28

Insights: Letrozole and Early Miscarriage Management

Written by Kenya Lyons, MD The administration of mifepristone followed by misoprostol is a highly effective regimen for the management of first-trimester miscarriage and medication abortion.1 However, even prior to the onset of legal challenges to mifepristone, including FDA v. Alliance for Hippocratic Medicine, the search for alternative therapies existed. This has been driven by…

May 21

Contraceptive Pearl: Ulipristal Acetate Myths

Written by Veronica Flake, MD Ulipristal Acetate (ella, UPA) is an effective emergency contraception (EC) method, given as a one-time, 30-mg dose, which can be used for up to 120 hours after unprotected sexual intercourse to prevent pregnancy. UPA is a selective progesterone receptor modulator with antagonistic and partial agonistic effects that prevents or delays…

May 10

Progestin-Only Birth Control Sheet

Some people prefer to take hormonal birth control without estrogen. This fact sheet highlights the progestin-only options that are available.   Spanish: Updated 2022 Reading Grade Level (Flesch-Kincaid Grade Level): 6.2     Sources: CDC – Injectables – US SPR – Reproductive Health. Centers for Disease Control and Prevention. https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/injectables.html. Published May 20, 2021. Accessed…

Apr 23

Insights: Part Two: Misoprostol-only Medication Abortion

Written by Brandy Bautista This article was published in April 2024, before the Supreme Court released its ruling in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration on June 13th. In its ruling, the Supreme Court unanimously rejected the challenge to mifepristone access. While we celebrate this decision, we know this will not…

Apr 16

Know Your State’s Abortion Laws Guides for Medical Providers

Since the Supreme Court overturned Roe v. Wade, medical providers in states where abortion is banned or severely restricted have struggled to understand how state laws apply to them and their patients. This resource from the Abortion Defense Network aims to provide clarification, where possible, of what conduct is permitted in the states where the…